ArticleScientific reports2025

Combined delivery of IL12 and an IL18 mutant without IL18BP-binding activity by an adenoviral vector enhances tumor specific immunity.

Yan Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.